IE
BGMD

Israel Englander’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

Israel Englander’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-125,000
Closed -$665K – 3778
2013
Q2 		$665K Buy
+125,000
New +$833K ﹤0.01% 2192

Other funds holding BGMD

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Israel Englander's BGMD Position: Q3 2013 in Review

Israel Englander sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2013, closing a stake of 125,000 shares — an estimated $665K sold.

Israel Englander first reported a position in BGMD in Q2 2013 and held it in 1 quarter. The position peaked at $665K in Q2 2013. 23 funds tracked by Wall St. Rank hold BGMD as of Q3 2013.

  • Israel Englander reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2013 after selling out during the quarter.
  • Israel Englander sold 125,000 BG MEDICINE INC COM STK NEW shares in Q3 2013, an estimated $665K.
  • Israel Englander first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and held it in 1 quarter.
  • Israel Englander's BG MEDICINE INC COM STK NEW position peaked at $665K in Q2 2013.
  • 23 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2013.

Based on Millennium Management's 13F filing for Q3 2013, filed 14 Nov 2013.